Bay Area's Pionyr Immunotherapeutics Scores $62M to Push Anti-Tumor Tech Towards Clinic Post author:Sam Post published:December 12, 2017 Post category:BioPharma Pionyr was founded in 2015 by a UCSF professor and a Genentech alum. Source: BioSpace You Might Also Like Orchard Therapeutics Scoops Up $110M in Funding to Advance "Bubble Boy Syndrome" Gene Therapy December 19, 2017 Safety Concerns Raised as Ionis Pharma's Inotersen Meets Both Primary Endpoints in Late-Stage Study May 14, 2017 Bay Area's Global Blood Therapeutics Terminates Lung Disease Program October 22, 2017
Orchard Therapeutics Scoops Up $110M in Funding to Advance "Bubble Boy Syndrome" Gene Therapy December 19, 2017
Safety Concerns Raised as Ionis Pharma's Inotersen Meets Both Primary Endpoints in Late-Stage Study May 14, 2017
